<unk>  is a Dipeptidyl peptidase-4 inhibitor that is FDA approved for the {{{indicationType}}} of type 2 diabetes mellitus.   Common adverse reactions include upper respiratory tract infection, urinary tract infection, and headache.
Saxagliptin
Linagliptin
Sitagliptin
Vildagliptin
Liraglutide
Exenatide
Canagliflozin
Pioglitazone